HYUNDAI BIOLAND Co.Ltd (052260) - Cash Flow Conversion Efficiency
Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.09 Billion ≈ $9.55 Million USD) by net assets (₩137.95 Billion ≈ $93.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HYUNDAI BIOLAND Co.Ltd balance sheet independence to measure how much of total assets are equity-financed.
HYUNDAI BIOLAND Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is HYUNDAI BIOLAND Co.Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
HYUNDAI BIOLAND Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of HYUNDAI BIOLAND Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metrod Holdings Bhd
KLSE:6149
|
0.290x |
|
Myomo Inc
NYSE MKT:MYO
|
-0.244x |
|
Dental Corporation Public Company Limited
BK:D
|
0.064x |
|
Ferroamp Elektronik AB
ST:FERRO
|
-0.003x |
|
Canterra Minerals Corporation
V:CTM
|
-0.091x |
|
Kutcho Copper Corp
V:KC
|
-0.010x |
|
OnKure Therapeutics, Inc.
NASDAQ:OKUR
|
-0.196x |
|
Zhong An Group Limited
F:35Z
|
0.005x |
Annual Cash Flow Conversion Efficiency for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market value of HYUNDAI BIOLAND Co.Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩138.01 Billion ≈ $93.53 Million |
₩4.60 Billion ≈ $3.12 Million |
0.033x | -18.86% |
| 2023-12-31 | ₩135.98 Billion ≈ $92.15 Million |
₩5.59 Billion ≈ $3.79 Million |
0.041x | -53.04% |
| 2022-12-31 | ₩129.29 Billion ≈ $87.62 Million |
₩11.31 Billion ≈ $7.67 Million |
0.087x | -48.93% |
| 2021-12-31 | ₩125.35 Billion ≈ $84.95 Million |
₩21.48 Billion ≈ $14.55 Million |
0.171x | +162.43% |
| 2020-12-31 | ₩137.23 Billion ≈ $93.00 Million |
₩8.96 Billion ≈ $6.07 Million |
0.065x | -10.45% |
| 2019-12-31 | ₩155.72 Billion ≈ $105.53 Million |
₩11.35 Billion ≈ $7.69 Million |
0.073x | -31.58% |
| 2018-12-31 | ₩148.91 Billion ≈ $100.91 Million |
₩15.87 Billion ≈ $10.75 Million |
0.107x | +4.79% |
| 2017-12-31 | ₩137.82 Billion ≈ $93.40 Million |
₩14.01 Billion ≈ $9.50 Million |
0.102x | +3.39% |
| 2016-12-31 | ₩130.53 Billion ≈ $88.46 Million |
₩12.84 Billion ≈ $8.70 Million |
0.098x | +5.23% |
| 2015-12-31 | ₩121.82 Billion ≈ $82.55 Million |
₩11.38 Billion ≈ $7.71 Million |
0.093x | -13.83% |
| 2014-12-31 | ₩114.48 Billion ≈ $77.58 Million |
₩12.42 Billion ≈ $8.41 Million |
0.108x | -32.23% |
| 2013-12-31 | ₩107.40 Billion ≈ $72.78 Million |
₩17.19 Billion ≈ $11.65 Million |
0.160x | +35.42% |
| 2012-12-31 | ₩100.65 Billion ≈ $68.21 Million |
₩11.90 Billion ≈ $8.06 Million |
0.118x | -28.25% |
| 2011-12-31 | ₩93.29 Billion ≈ $63.22 Million |
₩15.37 Billion ≈ $10.41 Million |
0.165x | -- |
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more